Search - tctmd.com

Displaying 181 - 200 of 1293

Sort: Relevancy | Date

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

May 14, 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

May 10, 2024

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

News Conference News SCAI 2024

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

May 07, 2024

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

May 03, 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

News Conference News EHRA 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

April 16, 2024

Should Conduction-System Pacing Be Top Choice for CRT?

News Conference News EHRA 2024

Should Conduction-System Pacing Be Top Choice for CRT?

April 15, 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

April 15, 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

News Conference News EHRA 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

April 11, 2024

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

News Conference News ACC 2024

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

April 11, 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

April 10, 2024

Need a Statin for Primary Prevention? There’s an App for That

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

April 10, 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 06, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.